Anti-Beta-2 Glycoprotein 1 Domain 1, IgG
Ordering Recommendation
Use as part of the laboratory workup for antiphospholipid syndrome (APS) when criteria antibodies (anti-cardiolipin and anti-beta2 glycoprotein 1 IgG/IgM) are of low titers or undetectable.
New York DOH Approval Status
Specimen Required
Serum separator tube (SST) or citrated plasma
Separate serum or plasma from cells as soon as possible or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP standard transport tube. (Min: 0.3 mL)
Refrigerated (2-8 degrees C).
Contaminated, heat-inactivated, clots, fibrin, gross red blood cells, severely lipemic, severely hemolyzed, or severely icteric specimens.
After separation from cells:
Room temperature: 48 hours
Refrigerated: 2 weeks
Frozen: 30 days (avoid repeated freeze-thaw cycles, but up to 3 freeze-thaw cycles is acceptable)
Methodology
Semi-Quantitative Chemiluminescent Immunoassay (CLIA)
Performed
Mon, Wed, Fri
Reported
1-5 days
Reference Interval
| Test Number |
Components |
Reference Interval |
|---|---|---|
| B2Glycoprotein 1 Domain 1, IgG Antibody | 0.0-19.9 CU: Negative |
Interpretive Data
IgG autoantibodies to the domain-1 of the beta-2 glycoprotein protein (anti-B2GP1-D1) are a subset of anti-B2GP1 antibodies that have been linked to thrombotic and/or obstetric complications in individuals with antiphospholipid syndrome (APS). Anti-B2GP1-D1 antibodies have been found to be of high specificity for APS diagnosis. Note that anti-B2GP1-D1 are not included in the ACR/EULAR APS classification criteria.
FDA
Note
Hotline History
Hotline History
CPT Codes
86146
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3020920 | B2Glycoprotein 1 Domain 1, IgG Antibody |
Aliases
- Anti-B2-glycoprotein 1 domain 1
- B2-glycoprotein 1 domain 1
- Anti-Beta-2-glycoprotein 1 domain 1
- Beta-2-glycoprotein 1 domain 1
- Anti-Domain 1 Beta-2 Glycoprotein 1
- Beta 2 GP1 domain 1 Ab IgG
- Beta 2GP1 domain 1 Ab
- Anti-B2GP 1 domain 1
















